FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:VPS53-NXN

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: VPS53-NXN
FusionPDB ID: 98486
FusionGDB2.0 ID: 98486
HgeneTgene
Gene symbol

VPS53

NXN

Gene ID

55275

64359

Gene nameVPS53 subunit of GARP complexnucleoredoxin
SynonymsHCCS1|PCH2E|hVps53L|pp13624NRX|RRS2|TRG-4
Cytomap

17p13.3

17p13.3

Type of geneprotein-codingprotein-coding
Descriptionvacuolar protein sorting-associated protein 53 homologVPS53, GARP complex subunitnucleoredoxinnucleoredoxin 1
Modification date2020031320200327
UniProtAcc..
Ensembl transtripts involved in fusion geneENST idsENST00000291074, ENST00000401468, 
ENST00000437048, ENST00000571805, 
ENST00000574029, ENST00000446250, 
ENST00000576149, 
ENST00000537628, 
ENST00000575801, ENST00000577098, 
ENST00000538650, ENST00000336868, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score18 X 15 X 14=378017 X 15 X 5=1275
# samples 2420
** MAII scorelog2(24/3780*10)=-3.97727992349992
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(20/1275*10)=-2.6724253419715
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: VPS53 [Title/Abstract] AND NXN [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: VPS53 [Title/Abstract] AND NXN [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)NXN(722678)-VPS53(465985), # samples:1
NXN(722679)-VPS53(465985), # samples:1
VPS53(613773)-NXN(729318), # samples:1
Anticipated loss of major functional domain due to fusion event.NXN-VPS53 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
NXN-VPS53 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
VPS53-NXN seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
VPS53-NXN seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
NXN-VPS53 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF.
NXN-VPS53 seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:722678/chr17:465985)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across VPS53 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across NXN (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000437048VPS53chr17613773-ENST00000336868NXNchr17729318-28993151471262371
ENST00000574029VPS53chr17613773-ENST00000336868NXNchr17729318-28732891211236371
ENST00000291074VPS53chr17613773-ENST00000336868NXNchr17729318-28863021341249371
ENST00000571805VPS53chr17613773-ENST00000336868NXNchr17729318-28893051371252371
ENST00000401468VPS53chr17613773-ENST00000336868NXNchr17729318-275216801115371

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000437048ENST00000336868VPS53chr17613773-NXNchr17729318-0.0039263170.9960737
ENST00000574029ENST00000336868VPS53chr17613773-NXNchr17729318-0.0037625380.9962374
ENST00000291074ENST00000336868VPS53chr17613773-NXNchr17729318-0.0039437620.9960562
ENST00000571805ENST00000336868VPS53chr17613773-NXNchr17729318-0.0039119460.996088
ENST00000401468ENST00000336868VPS53chr17613773-NXNchr17729318-0.0037415210.9962585

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for VPS53-NXN

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
VPS53chr17613773NXNchr1772931816855NAVEYINTLFPTEQLKLWNKYRISNI
VPS53chr17613773NXNchr1772931828955NAVEYINTLFPTEQLKLWNKYRISNI
VPS53chr17613773NXNchr1772931830255NAVEYINTLFPTEQLKLWNKYRISNI
VPS53chr17613773NXNchr1772931830555NAVEYINTLFPTEQLKLWNKYRISNI
VPS53chr17613773NXNchr1772931831555NAVEYINTLFPTEQLKLWNKYRISNI

Top

Potential FusionNeoAntigen Information of VPS53-NXN in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
VPS53-NXN_613773_729318.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
VPS53-NXNchr17613773chr17729318302HLA-B35:03FPTEQLKL0.97650.7844917
VPS53-NXNchr17613773chr17729318302HLA-B35:02FPTEQLKL0.87210.7381917
VPS53-NXNchr17613773chr17729318302HLA-B35:04FPTEQLKL0.87210.7381917
VPS53-NXNchr17613773chr17729318302HLA-B35:01FPTEQLKLW0.99560.7713918
VPS53-NXNchr17613773chr17729318302HLA-B35:05FPTEQLKLW0.99440.5303918
VPS53-NXNchr17613773chr17729318302HLA-B35:08FPTEQLKLW0.98820.7469918
VPS53-NXNchr17613773chr17729318302HLA-B58:02FPTEQLKLW0.95380.8572918
VPS53-NXNchr17613773chr17729318302HLA-B18:01EQLKLWNKY0.94950.56571221
VPS53-NXNchr17613773chr17729318302HLA-B15:02EQLKLWNKY0.93810.71151221
VPS53-NXNchr17613773chr17729318302HLA-A30:08TLFPTEQLK0.83760.6835716
VPS53-NXNchr17613773chr17729318302HLA-B44:03TEQLKLWNKY0.99970.81521121
VPS53-NXNchr17613773chr17729318302HLA-A02:22TLFPTEQLKL0.98820.6587717
VPS53-NXNchr17613773chr17729318302HLA-B18:01TEQLKLWNKY0.98120.69181121
VPS53-NXNchr17613773chr17729318302HLA-A02:27TLFPTEQLKL0.97880.6902717
VPS53-NXNchr17613773chr17729318302HLA-A02:11TLFPTEQLKL0.96740.6756717
VPS53-NXNchr17613773chr17729318302HLA-A02:60TLFPTEQLKL0.96650.6221717
VPS53-NXNchr17613773chr17729318302HLA-A02:67TLFPTEQLKL0.9660.6371717
VPS53-NXNchr17613773chr17729318302HLA-A02:30TLFPTEQLKL0.9660.6371717
VPS53-NXNchr17613773chr17729318302HLA-A02:24TLFPTEQLKL0.9660.6371717
VPS53-NXNchr17613773chr17729318302HLA-A02:04TLFPTEQLKL0.95840.6958717
VPS53-NXNchr17613773chr17729318302HLA-A02:38TLFPTEQLKL0.95410.7001717
VPS53-NXNchr17613773chr17729318302HLA-A02:16TLFPTEQLKL0.95010.502717
VPS53-NXNchr17613773chr17729318302HLA-B53:01LFPTEQLKLW0.91680.5273818
VPS53-NXNchr17613773chr17729318302HLA-A02:35TLFPTEQLKL0.87780.6739717
VPS53-NXNchr17613773chr17729318302HLA-A02:19TLFPTEQLKL0.83120.5497717
VPS53-NXNchr17613773chr17729318302HLA-A02:29TLFPTEQLKL0.79770.6418717
VPS53-NXNchr17613773chr17729318302HLA-A02:20TLFPTEQLKL0.79450.6407717
VPS53-NXNchr17613773chr17729318302HLA-B57:01TLFPTEQLKLW0.99990.9818718
VPS53-NXNchr17613773chr17729318302HLA-B58:02TLFPTEQLKLW0.99960.963718
VPS53-NXNchr17613773chr17729318302HLA-B58:01TLFPTEQLKLW0.99880.963718
VPS53-NXNchr17613773chr17729318302HLA-B57:03TLFPTEQLKLW0.99850.9808718
VPS53-NXNchr17613773chr17729318302HLA-A32:13TLFPTEQLKLW0.99830.9751718
VPS53-NXNchr17613773chr17729318302HLA-B53:01TLFPTEQLKLW0.98480.5608718
VPS53-NXNchr17613773chr17729318302HLA-B35:12FPTEQLKL0.87210.7381917
VPS53-NXNchr17613773chr17729318302HLA-B42:01FPTEQLKL0.81480.5266917
VPS53-NXNchr17613773chr17729318302HLA-B39:10FPTEQLKL0.6220.8351917
VPS53-NXNchr17613773chr17729318302HLA-B15:21EQLKLWNKY0.93230.65071221
VPS53-NXNchr17613773chr17729318302HLA-B15:05EQLKLWNKY0.89610.51681221
VPS53-NXNchr17613773chr17729318302HLA-B15:31EQLKLWNKY0.86280.53211221
VPS53-NXNchr17613773chr17729318302HLA-C07:29LFPTEQLKL0.53590.9626817
VPS53-NXNchr17613773chr17729318302HLA-C07:13LFPTEQLKL0.50930.94817
VPS53-NXNchr17613773chr17729318302HLA-C04:14LFPTEQLKL0.4630.8408817
VPS53-NXNchr17613773chr17729318302HLA-C04:10LFPTEQLKL0.41120.8599817
VPS53-NXNchr17613773chr17729318302HLA-C04:07LFPTEQLKL0.38230.8791817
VPS53-NXNchr17613773chr17729318302HLA-C01:30LFPTEQLKL0.1550.96817
VPS53-NXNchr17613773chr17729318302HLA-C01:17LFPTEQLKL0.08970.9465817
VPS53-NXNchr17613773chr17729318302HLA-A02:01TLFPTEQLKL0.9660.6371717
VPS53-NXNchr17613773chr17729318302HLA-B35:13FPTEQLKL0.98250.7888917
VPS53-NXNchr17613773chr17729318302HLA-B35:17FPTEQLKL0.97910.6162917
VPS53-NXNchr17613773chr17729318302HLA-B35:30FPTEQLKL0.97910.6162917
VPS53-NXNchr17613773chr17729318302HLA-B35:24FPTEQLKL0.87640.7792917
VPS53-NXNchr17613773chr17729318302HLA-B35:09FPTEQLKL0.87210.7381917
VPS53-NXNchr17613773chr17729318302HLA-B67:01FPTEQLKL0.70070.6432917
VPS53-NXNchr17613773chr17729318302HLA-B08:12FPTEQLKL0.65280.6496917
VPS53-NXNchr17613773chr17729318302HLA-B35:77FPTEQLKLW0.99560.7713918
VPS53-NXNchr17613773chr17729318302HLA-B35:23FPTEQLKLW0.9950.732918
VPS53-NXNchr17613773chr17729318302HLA-B35:17FPTEQLKLW0.99490.6278918
VPS53-NXNchr17613773chr17729318302HLA-B35:30FPTEQLKLW0.99490.6278918
VPS53-NXNchr17613773chr17729318302HLA-B15:13FPTEQLKLW0.9910.6162918
VPS53-NXNchr17613773chr17729318302HLA-B35:24FPTEQLKLW0.98510.7889918
VPS53-NXNchr17613773chr17729318302HLA-B15:27EQLKLWNKY0.98360.59231221
VPS53-NXNchr17613773chr17729318302HLA-B15:135EQLKLWNKY0.98270.57451221
VPS53-NXNchr17613773chr17729318302HLA-B15:50EQLKLWNKY0.96560.63521221
VPS53-NXNchr17613773chr17729318302HLA-C03:06NTLFPTEQL0.95910.992615
VPS53-NXNchr17613773chr17729318302HLA-B18:04EQLKLWNKY0.95760.59821221
VPS53-NXNchr17613773chr17729318302HLA-B18:07EQLKLWNKY0.95570.53841221
VPS53-NXNchr17613773chr17729318302HLA-B18:05EQLKLWNKY0.94950.56571221
VPS53-NXNchr17613773chr17729318302HLA-B18:11EQLKLWNKY0.94050.53771221
VPS53-NXNchr17613773chr17729318302HLA-B18:06EQLKLWNKY0.93880.55721221
VPS53-NXNchr17613773chr17729318302HLA-B18:03EQLKLWNKY0.92750.55061221
VPS53-NXNchr17613773chr17729318302HLA-A68:02NTLFPTEQL0.91380.8155615
VPS53-NXNchr17613773chr17729318302HLA-B15:12EQLKLWNKY0.91170.55271221
VPS53-NXNchr17613773chr17729318302HLA-B15:20EQLKLWNKY0.89830.64061221
VPS53-NXNchr17613773chr17729318302HLA-B35:28EQLKLWNKY0.87130.64361221
VPS53-NXNchr17613773chr17729318302HLA-B15:24EQLKLWNKY0.86520.57131221
VPS53-NXNchr17613773chr17729318302HLA-B35:20EQLKLWNKY0.83840.67131221
VPS53-NXNchr17613773chr17729318302HLA-A69:01NTLFPTEQL0.83720.8622615
VPS53-NXNchr17613773chr17729318302HLA-B48:02EQLKLWNKY0.54670.59361221
VPS53-NXNchr17613773chr17729318302HLA-C04:04LFPTEQLKL0.49950.8653817
VPS53-NXNchr17613773chr17729318302HLA-B18:07FPTEQLKLW0.42990.7993918
VPS53-NXNchr17613773chr17729318302HLA-C18:01LFPTEQLKL0.39540.8816817
VPS53-NXNchr17613773chr17729318302HLA-C04:01LFPTEQLKL0.38230.8791817
VPS53-NXNchr17613773chr17729318302HLA-A25:01FPTEQLKLW0.27910.9225918
VPS53-NXNchr17613773chr17729318302HLA-C14:02LFPTEQLKL0.19340.9574817
VPS53-NXNchr17613773chr17729318302HLA-C14:03LFPTEQLKL0.19340.9574817
VPS53-NXNchr17613773chr17729318302HLA-C01:03LFPTEQLKL0.07510.9105817
VPS53-NXNchr17613773chr17729318302HLA-C01:02LFPTEQLKL0.07360.9423817
VPS53-NXNchr17613773chr17729318302HLA-B44:26TEQLKLWNKY0.99970.81521121
VPS53-NXNchr17613773chr17729318302HLA-B44:07TEQLKLWNKY0.99970.81521121
VPS53-NXNchr17613773chr17729318302HLA-B44:13TEQLKLWNKY0.99970.81521121
VPS53-NXNchr17613773chr17729318302HLA-A02:03TLFPTEQLKL0.98870.8001717
VPS53-NXNchr17613773chr17729318302HLA-B18:05TEQLKLWNKY0.98120.69181121
VPS53-NXNchr17613773chr17729318302HLA-A02:14TLFPTEQLKL0.96150.6882717
VPS53-NXNchr17613773chr17729318302HLA-B18:11TEQLKLWNKY0.95940.62521121
VPS53-NXNchr17613773chr17729318302HLA-B53:02LFPTEQLKLW0.92820.566818
VPS53-NXNchr17613773chr17729318302HLA-B57:10TLFPTEQLKLW0.99990.9818718
VPS53-NXNchr17613773chr17729318302HLA-B57:04TLFPTEQLKLW0.99980.7823718
VPS53-NXNchr17613773chr17729318302HLA-B15:24TLFPTEQLKLW0.99970.9631718
VPS53-NXNchr17613773chr17729318302HLA-A32:01TLFPTEQLKLW0.99890.9901718
VPS53-NXNchr17613773chr17729318302HLA-B15:13TLFPTEQLKLW0.99840.8837718
VPS53-NXNchr17613773chr17729318302HLA-B53:02TLFPTEQLKLW0.97290.6528718

Top

Potential FusionNeoAntigen Information of VPS53-NXN in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
VPS53-NXN_613773_729318.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
VPS53-NXNchr17613773chr17729318302DRB1-1102PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1102TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1102FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1103PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1103TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1114TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1114PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1116PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1116TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1116FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1120TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1120PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1121TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1121PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1121FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1136PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1136TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1148PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1148TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1155TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1155PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1159PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1159TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1163PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1163TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1165PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1165TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1165FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1168TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1168PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1170TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1170PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1170FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1176PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1176TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1185PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1185TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1186TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1186PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1301PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1301TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1301FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1302TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1302PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1304PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1304TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1304FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1308PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1308TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1309PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1309TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1315TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1315PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1315FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1316TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1316PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1317PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1317TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1317FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1319TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1319PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1319FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1320PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1320TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1322PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1322TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1322FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1323TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1323PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1324PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1324TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1327PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1327TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1329TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1329PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1331TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1331PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1332PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1332TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1334TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1334PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1335PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1335TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1335FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1336TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1336PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1339TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1339PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1343PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1343TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1343FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1348PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1348TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1351PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1351TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1351FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1352PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1352TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1352FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1353TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1353PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1353FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1354PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1354TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1354FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1357TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1357PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1357FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1359PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1359TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1359FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1361TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1361PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1364PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1364TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1364FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1368PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1368TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1368FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1369PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1369TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1369FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1370PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1370TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1371PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1371TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1372PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1372TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1373TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1373PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1374TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1374PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1375PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1375TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1376PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1376TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1378PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1378TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1379PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1379TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1379FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1380PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1380TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1380FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1383PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1383TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1383FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1384PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1384TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1387PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1387TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1387FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1391PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1391TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1391FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1392PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1392TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1392FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1393PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1393TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1393FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1397TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1397PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1398PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1398TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1398FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1399TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1399PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1416PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1416TEQLKLWNKYRISNI1126
VPS53-NXNchr17613773chr17729318302DRB1-1416FPTEQLKLWNKYRIS924
VPS53-NXNchr17613773chr17729318302DRB1-1437PTEQLKLWNKYRISN1025
VPS53-NXNchr17613773chr17729318302DRB1-1437TEQLKLWNKYRISNI1126

Top

Fusion breakpoint peptide structures of VPS53-NXN

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
6420NTLFPTEQLKLWNKVPS53NXNchr17613773chr17729318302

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of VPS53-NXN

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN6420NTLFPTEQLKLWNK-7.9962-8.1096
HLA-B14:023BVN6420NTLFPTEQLKLWNK-5.70842-6.74372
HLA-B52:013W396420NTLFPTEQLKLWNK-6.83737-6.95077
HLA-B52:013W396420NTLFPTEQLKLWNK-4.4836-5.5189
HLA-A11:014UQ26420NTLFPTEQLKLWNK-10.0067-10.1201
HLA-A11:014UQ26420NTLFPTEQLKLWNK-9.03915-10.0745
HLA-A24:025HGA6420NTLFPTEQLKLWNK-6.56204-6.67544
HLA-A24:025HGA6420NTLFPTEQLKLWNK-5.42271-6.45801
HLA-B44:053DX86420NTLFPTEQLKLWNK-7.85648-8.89178
HLA-B44:053DX86420NTLFPTEQLKLWNK-5.3978-5.5112
HLA-A02:016TDR6420NTLFPTEQLKLWNK-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of VPS53-NXN

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
VPS53-NXNchr17613773chr177293181121TEQLKLWNKYGAGCAACTCAAACTTTGGAACAAATACCGA
VPS53-NXNchr17613773chr177293181221EQLKLWNKYCAACTCAAACTTTGGAACAAATACCGA
VPS53-NXNchr17613773chr17729318615NTLFPTEQLACCCTGTTCCCAACCGAGCAACTCAAA
VPS53-NXNchr17613773chr17729318716TLFPTEQLKCTGTTCCCAACCGAGCAACTCAAACTT
VPS53-NXNchr17613773chr17729318717TLFPTEQLKLCTGTTCCCAACCGAGCAACTCAAACTTTGG
VPS53-NXNchr17613773chr17729318718TLFPTEQLKLWCTGTTCCCAACCGAGCAACTCAAACTTTGGAAC
VPS53-NXNchr17613773chr17729318817LFPTEQLKLTTCCCAACCGAGCAACTCAAACTTTGG
VPS53-NXNchr17613773chr17729318818LFPTEQLKLWTTCCCAACCGAGCAACTCAAACTTTGGAAC
VPS53-NXNchr17613773chr17729318917FPTEQLKLCCAACCGAGCAACTCAAACTTTGG
VPS53-NXNchr17613773chr17729318918FPTEQLKLWCCAACCGAGCAACTCAAACTTTGGAAC

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
VPS53-NXNchr17613773chr177293181025PTEQLKLWNKYRISNACCGAGCAACTCAAACTTTGGAACAAATACCGAATTTCCAACATT
VPS53-NXNchr17613773chr177293181126TEQLKLWNKYRISNIGAGCAACTCAAACTTTGGAACAAATACCGAATTTCCAACATTCCA
VPS53-NXNchr17613773chr17729318924FPTEQLKLWNKYRISCCAACCGAGCAACTCAAACTTTGGAACAAATACCGAATTTCCAAC

Top

Information of the samples that have these potential fusion neoantigens of VPS53-NXN

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
LUADVPS53-NXNchr17613773ENST00000291074chr17729318ENST00000336868TCGA-50-5066-02A

Top

Potential target of CAR-T therapy development for VPS53-NXN

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to VPS53-NXN

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to VPS53-NXN

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource